Recent Patents on Anti-Cancer Drug Discovery

Personal Subscription
Become EABM
Become Reviewer

Review of Selected Patents for Cancer Therapy Targeting Tumor Angiogenesis

Volume:1   Issue: 2
Pp: 153-161
Mark N. Kirstein, Megan M. Moore and Arkadiusz Z. Dudek
DOI: 10.2174/157489206777442269

Recent Developments to Improve the Efficacy of Cytotoxic Nucleoside Analogues

Volume:1   Issue: 2
Pp: 163-170
Lars P. Jordheim, Carlos M. Galmarini and Charles Dumontet
DOI: 10.2174/157489206777442205

Thymidine Phosphorylase (Platelet-Derived Endothelial Cell Growth Factor) as a Target for Capecitabine: From Biology to the Bedside

Volume:1   Issue: 2
Pp: 171-183
Girolamo Ranieri, Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
DOI: 10.2174/157489206777442241

Tetraplex Binding Molecules as Anti-Cancer Agents

Volume:1   Issue: 2
Pp: 185-200
Kevin M. Doherty, Sudha Sharma, Rigu Gupta and Robert M. Brosh Jr.
DOI: 10.2174/157489206777442232

EGF-R Small Inhibitors and Anti-EGF-R Antibodies: Advantages and Limits of a New Avenue in Anticancer Therapy

Volume:1   Issue: 2
Pp: 209-222
Michele Caraglia, Monica Marra, Giusy Meo, Raffaele Addeo, Pierosandro Tagliaferri and Alfredo Budillon
DOI: 10.2174/157489206777442250

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors

Volume:1   Issue: 2
Pp: 237-254
Gabriela Melen-Mucha, Hanna Lawnicka, Dorota Kierszniewska-Stepien, Jan Komorowski and Henryk Stepien
DOI: 10.2174/157489206777442197

Recent Patents Therapeutic Agents for Cancer

Volume:1   Issue: 2
Pp: 255-284
Xun Li and Wenfang Xu
DOI: 10.2174/157489206777442188

Patent Annotations

Volume:1   Issue: 2
Pp: 297-302
Bentham Science Publishers
DOI: 10.2174/157489206777442223

Patent Selections promotion: free to download

Volume:1   Issue: 2
Pp: 303-304
Bentham Science Publishers
DOI: 10.2174/157489206777442278